Abstract:7-Ethyl-10-hydroxycamptothecin (SN-38) is a potent broad-spectrum antitumor drug derived from irinotecan hydrochloride (CPT-11). Due to its poor solubility and instability of the active lactone ring, its clinical use is significantly limited. As one of the most promising formulations for poorly water-soluble drugs, nanocrystals have attracted increasing attention. In order to solve these problems and evaluate the antitumor effect of SN-38 in vitro and in vivo, two nanocrystals with markedly different particle sizes were prepared. Dynamic light scattering and transmission electron microscopy were used to investigate the two nanocrystals. The particle sizes of SN-38 nanocrystals A (SN-38/NCs-A) and SN-38 nanocrystals B (SN-38/NCs-B) were 229.5±1.99 and 799.2±14.44 nm, respectively. X-ray powder diffraction analysis showed that the crystalline state of SN-38 did not change in the size reduction process. An accelerated dissolution velocity of SN-38 was achieved by nanocrystals, and release rate of SN-38/NCs-A was significantly faster than that of SN-38/NCs-B. Cellular uptake, cellular cytotoxicity, pharmacokinetics, animal antitumor efficacy, and tissue distribution were subsequently examined. As a result, enhanced intracellular accumulation in HT1080 cells and cytotoxicity on different tumor cells were observed for SN-38/NCs-A compared to that for SN-38/NCs-B and solution. Besides, compared to the SN-38 solution, SN-38/NCs-A had a higher bioavailability after intravenous injection; while the bioavailability of SN-38/NCs-B was even lower than that of the SN-38 solution. SN-38/NCs-A exhibited a significant inhibition of tumor growth compared to SN-38 solution and SN-38/NCs-B in vivo. The antitumor effect of SN-38/NCs-B was stronger than SN-38 solution. The tissue distribution study in tumor-bearing mice showed that nanocrystals could markedly improve the drug accumulation in tumor tissue by the enhanced permeability and retention effect compared to SN-38 solution, and the amount of SN-38 in tumors of SN-38/NCs-A group was much more than that of SN-38/NCs-B group. In conclusion, nanocrystals dramatically enhanced the anticancer efficacy of SN-38 in vitro and in vivo, and the particle size had a significant influence on the dissolution behavior, pharmacokinetic properties, and tumor inhibition of nanocrystals.

STUDIES ON CAMPTOTHECIN SOLID LIPID NANOPARTICLES

Preparation And Characterization Of Camptothecin Solid Lipid Nanoparticles

Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain.

Body Distribution of Camptothecin Solid Lipid Nanoparticles after Oral Administration

Redox Sensitive Lipid-Camptothecin Conjugate Encapsulated Solid Lipid Nanoparticles for Oral Delivery.

Effect of Phospholipid Composition on Characterization of Liposomes Containing 9-Nitrocamptothecin.

Lipid Nanoparticles Loaded with 7-Ethyl-10-hydroxycamptothecin-phospholipid Complex: in Vitro and in Vivo Studies

Fabrication of nanomicelle with enhanced solubility and stability of camptothecin based on alpha,beta-poly[(N-carboxybutyl)-L-aspartamide]-camptothecin conjugate.

Intracellular target delivery of 10-hydroxycamptothecin with solid lipid nanoparticles against multidrug resistance

Nanocarrier Improves the Bioavailability, Stability and Antitumor Activity of Camptothecin

Fabrication of nanomicelle with enhanced solubility and stability of camptothecin based on α,β-poly[(N-carboxybutyl)-l-aspartamide]–camptothecin conjugate

Formulation of the novel structure curcumin derivative–loaded solid lipid nanoparticles: synthesis, optimization, characterization and anti-tumor activity screening in vitro

Core-crosslinked Nanomicelles Based on Crosslinkable Prodrug and Surfactants for Reduction Responsive Delivery of Camptothecin and Improved Anticancer Efficacy.

Mechanisms of Chitosan-Coated Poly(Lactic-Co-Glycolic Acid) Nanoparticles for Improving Oral Absorption of 7-Ethyl-10-hydroxycamptothecin

Fabrication of cationic nanomicelle from chitosan-graft-polycaprolactone as the carrier of 7-ethyl-10-hydroxy-camptothecin.

In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizes

Combretastatin A4-loaded Poly (Lactic-Co-glycolic Acid)/Soybean Lecithin Nanoparticles with Enhanced Drug Dissolution Rate and Antiproliferation Activity.

Fabrication of Novel Microcapsules for Controlled Release of Camptothecin

Preparation and in Vitro Release of CA4-loaded Solid Lipid Nanoparticles

Preparation and characterization of novel polymeric micelles for 9-nitro-20(S)-camptothecin delivery.